Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease

  1. Alexa Pichet Binette  Is a corresponding author
  2. Guillaume Theaud
  3. François Rheault
  4. Maggie Roy
  5. D Louis Collins
  6. Johannes Levin
  7. Hiroshi Mori
  8. Jae Hong Lee
  9. Martin Rhys Farlow
  10. Peter Schofield
  11. Jasmeer P Chhatwal
  12. Colin L Masters
  13. Tammie Benzinger
  14. john Morris
  15. Randall Bateman
  16. John CS Breitner
  17. Judes Poirier
  18. Julie Gonneaud
  19. Maxime Descoteaux
  20. Sylvia Villeneuve  Is a corresponding author
  21. for the DIAN Study Group and the PREVENT-AD Research Group
  1. McGill University, Canada
  2. Université de Sherbrooke, Canada
  3. Montreal Neurological Institute and Hospital, Canada
  4. Ludwig-Maximilians-Universität München, Germany
  5. Osaka City University Medical School, Japan
  6. University of Ulsan College of Medicine, Asan Medical Center, Republic of Korea
  7. Indiana University, United States
  8. Neuroscience Research Australia, Australia
  9. Harvard Medical School, Massachusetts General Hospital, United States
  10. University of Melbourne, Australia
  11. Washington University School of Medicine, United States

Abstract

Beta-amyloid (Aβ) and tau proteins, the pathological hallmarks of Alzheimer's disease (AD), are believed to spread through connected regions of the brain. Combining diffusion imaging and positron emission tomography, we investigated associations between white matter microstructure specifically in bundles connecting regions where Aβ or tau accumulates and pathology. We focussed on free-water corrected diffusion measures in the anterior cingulum, posterior cingulum, and uncinate fasciculus in cognitively normal older adults at risk of sporadic AD and presymptomatic mutation carriers of autosomal dominant AD. In Aβ-positive or tau-positive groups, lower tissue fractional anisotropy and higher mean diffusivity related to greater Aβ and tau burden in both cohorts. Associations were found in the posterior cingulum and uncinate fasciculus in preclinical sporadic AD, and in the anterior and posterior cingulum in presymptomatic mutation carriers. These results suggest that microstructural alterations accompany pathological accumulation as early as the preclinical stage of both sporadic and autosomal dominant AD.

Data availability

All raw imaging data from PREVENT-AD is openly available to researchers on the data repository https://registeredpreventad.loris.ca/

The following data sets were generated
    1. Tremblay-Mercier et al.
    (2021) PREVENT-AD
    LORIS Repository, 10.5281/zenodo.4535262.

Article and author information

Author details

  1. Alexa Pichet Binette

    Psychiatry, McGill University, Montreal, Canada
    For correspondence
    alexa.pichetbinette@mail.mcgill.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5218-3337
  2. Guillaume Theaud

    Computer Science, Université de Sherbrooke, Sherbrooke, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. François Rheault

    Computer Science, Université de Sherbrooke, Sherbrooke, Canada
    Competing interests
    The authors declare that no competing interests exist.
  4. Maggie Roy

    Computer Science, Université de Sherbrooke, Sherbrooke, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. D Louis Collins

    McConnell Brain Imaging Centre, Montreal Neurological Institute, Montreal Neurological Institute and Hospital, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8432-7021
  6. Johannes Levin

    Neurology, Ludwig-Maximilians-Universität München, Munich, Germany
    Competing interests
    The authors declare that no competing interests exist.
  7. Hiroshi Mori

    Clinical Neuroscience, Osaka City University Medical School, Osaka, Japan
    Competing interests
    The authors declare that no competing interests exist.
  8. Jae Hong Lee

    Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea
    Competing interests
    The authors declare that no competing interests exist.
  9. Martin Rhys Farlow

    Neurology, Indiana University, Bloomington, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Peter Schofield

    Faculty of Medicine, Neuroscience Research Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  11. Jasmeer P Chhatwal

    Neurology, Harvard Medical School, Massachusetts General Hospital, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Colin L Masters

    University of Melbourne, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
  13. Tammie Benzinger

    Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. john Morris

    Washington University School of Medicine, St Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Randall Bateman

    Neurology, Washington University School of Medicine, St. Louis, United States
    Competing interests
    The authors declare that no competing interests exist.
  16. John CS Breitner

    Psychiatry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  17. Judes Poirier

    Psychiatry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  18. Julie Gonneaud

    Psychiatry, McGill University, Montreal, Canada
    Competing interests
    The authors declare that no competing interests exist.
  19. Maxime Descoteaux

    Computer Science, Université de Sherbrooke, Sherbrooke, Canada
    Competing interests
    The authors declare that no competing interests exist.
  20. Sylvia Villeneuve

    Psychiatry, McGill University, Montreal, Canada
    For correspondence
    sylvia.villeneuve@mcgill.ca
    Competing interests
    The authors declare that no competing interests exist.

Funding

Canadian Institutes of Health Research (PJT-162091)

  • Sylvia Villeneuve

Canadian Institutes of Health Research (PJT- 148963)

  • Sylvia Villeneuve

Levesque Foundation

  • Judes Poirier

Douglas Hospital Research Centre and Foundation

  • John CS Breitner

Canada Foundation for Innovation

  • Sylvia Villeneuve

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The study was approved by the ethics committee of the Faculty of Medicine of McGill University and of the Douglas Mental Health University Institute. Informed consent was obtained from all PREVENT-AD and DIAN participants prior to enrolling in the respective studies.We had access to the DIAN data with approval from DIAN leaders (data request DIAN-D1624).

Copyright

© 2021, Pichet Binette et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,324
    views
  • 300
    downloads
  • 33
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Alexa Pichet Binette
  2. Guillaume Theaud
  3. François Rheault
  4. Maggie Roy
  5. D Louis Collins
  6. Johannes Levin
  7. Hiroshi Mori
  8. Jae Hong Lee
  9. Martin Rhys Farlow
  10. Peter Schofield
  11. Jasmeer P Chhatwal
  12. Colin L Masters
  13. Tammie Benzinger
  14. john Morris
  15. Randall Bateman
  16. John CS Breitner
  17. Judes Poirier
  18. Julie Gonneaud
  19. Maxime Descoteaux
  20. Sylvia Villeneuve
  21. for the DIAN Study Group and the PREVENT-AD Research Group
(2021)
Bundle-specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease
eLife 10:e62929.
https://doi.org/10.7554/eLife.62929

Share this article

https://doi.org/10.7554/eLife.62929

Further reading

    1. Neuroscience
    Brian C Ruyle, Sarah Masud ... Jose A Morón
    Research Article

    Millions of Americans suffering from Opioid Use Disorders face a high risk of fatal overdose due to opioid-induced respiratory depression (OIRD). Fentanyl, a powerful synthetic opioid, is a major contributor to the rising rates of overdose deaths. Reversing fentanyl overdoses has proved challenging due to its high potency and the rapid onset of OIRD. We assessed the contributions of central and peripheral mu opioid receptors (MORs) in mediating fentanyl-induced physiological responses. The peripherally restricted MOR antagonist naloxone methiodide (NLXM) both prevented and reversed OIRD to a degree comparable to that of naloxone (NLX), indicating substantial involvement of peripheral MORs to OIRD. Interestingly, NLXM-mediated OIRD reversal did not produce aversive behaviors observed after NLX. We show that neurons in the nucleus of the solitary tract (nTS), the first central synapse of peripheral afferents, exhibit a biphasic activity profile following fentanyl exposure. NLXM pretreatment attenuates this activity, suggesting that these responses are mediated by peripheral MORs. Together, these findings establish a critical role for peripheral MORs, including ascending inputs to the nTS, as sites of dysfunction during OIRD. Furthermore, selective peripheral MOR antagonism could be a promising therapeutic strategy for managing OIRD by sparing CNS-driven acute opioid-associated withdrawal and aversion observed after NLX.

    1. Neuroscience
    David C Williams, Amanda Chu ... Michael A McDannald
    Research Advance Updated

    Recognizing and responding to threat cues is essential to survival. Freezing is a predominant threat behavior in rats. We have recently shown that a threat cue can organize diverse behaviors beyond freezing, including locomotion (Chu et al., 2024). However, that experimental design was complex, required many sessions, and had rats receive many foot shock presentations. Moreover, the findings were descriptive. Here, we gave female and male Long Evans rats cue light illumination paired or unpaired with foot shock (eight total) in a conditioned suppression setting using a range of shock intensities (0.15, 0.25, 0.35, or 0.50 mA). We found that conditioned suppression was only observed at higher foot shock intensities (0.35 mA and 0.50 mA). We constructed comprehensive temporal ethograms by scoring 22,272 frames across 12 behavior categories in 200-ms intervals around cue light illumination. The 0.50 mA and 0.35 mA shock-paired visual cues suppressed reward seeking, rearing, and scaling, as well as light-directed rearing and light-directed scaling. These shock-paired visual cues further elicited locomotion and freezing. Linear discriminant analyses showed that ethogram data could accurately classify rats into paired and unpaired groups. Using complete ethogram data produced superior classification compared to behavior subsets, including an immobility subset featuring freezing. The results demonstrate diverse threat behaviors – in a short and simple procedure – containing sufficient information to distinguish the visual fear conditioning status of individual rats.